Kristen Johnson
16Patents
4h-index
9Co-inventors
49Inventor score
Filing activity: Jul 13, 2010 → Dec 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9139633B2 | Mesenchymal stem cell differentiation | Human Necessities | 16 | Active |
| US9868771B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 7 | Active |
| US9649359B2 | Peptides and compositions for treatment of joint damage | Chemistry; Metallurgy | 5 | Active |
| US9301971B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 5 | Active |
| US10239927B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 4 | Active |
| US9745358B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 3 | Active |
| US10064918B2 | Mesenchymal stem cell differentiation | Human Necessities | 2 | Active |
| US11111283B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 1 | Active |
| US10464979B2 | FGF23 c-tail fusion proteins | Chemistry; Metallurgy | 1 | Active |
| US10328126B2 | Peptides and compositions for treatment of joint damage | Chemistry; Metallurgy | 1 | Active |
| US10555990B2 | Mesenchymal stem cell differentiation | Human Necessities | 1 | Active |
| US11179442B2 | Peptides and compositions for treatment of joint damage | Chemistry; Metallurgy | 1 | Active |
| US10533042B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 1 | Active |
| US11241482B2 | Mesenchymal stem cell differentiation | Human Necessities | 0 | Active |
| US11370820B2 | Peptides and compositions for treatment of joint damage | Emerging Cross-Sectional Technologies | 0 | Active |
| US11351223B2 | Methods and compositions for treatment of cartilage damage and arthritis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.